Supernus Pharmaceuticals inc (SUPN) - News Archive

In the realm of mental health, awareness is an empowering tool. From celebrities to everyday individuals, the narratives around conditions like Attention Deficit Hyperactivity Disorder (ADHD) are being shared more openl...

In a significant development within the field of neurology, Supernus Pharmaceuticals, Inc. has announced the resubmission of its New Drug Application (NDA) for SPN-830, an innovative apomorphine infusion device aimed at...

Epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures, affects millions of individuals worldwide. Despite numerous available treatments, a significant percentage of patients continue to suffe...

Supernus Pharmaceuticals, Inc., a biopharmaceutical firm headquartered in Rockville, Maryland, specializing in the development and commercialization of products for the treatment of central nervous system (CNS) diseases...